Tags: Virus Outbreak | Denmark

Denmark Prolongs Suspension of AstraZeneca COVID-19 Vaccine

Thursday, 25 March 2021 08:01 AM EDT

COPENHAGEN, Denmark (AP) — The Danish government decided Thursday to continue its suspension of the AstraZeneca COVID-19 for three more weeks.

Denmark paused the use of the AstraZeneca as a precautionary measure on March 11 after reports that a 60-year-old woman died with blood clots in several parts of her body a week after she received the vaccine, according to health officials.

The death of a second person in Denmark who died after getting the AstraZeneca vaccine was reported shortly after. Danish health authorities said they have no evidence the vaccine was responsible for either death.

Norway and Sweden also have paused the use of the AstraZeneca vaccine. Several European countries that had suspended using the vaccine have resumed administering it after the European Union's drug regulator said it was safe.

© Copyright 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.


GlobalTalk
The Danish government decided Thursday to continue its suspension of the AstraZeneca COVID-19 for three more weeks.Denmark paused the use of the AstraZeneca as a precautionary measure on March 11 after reports that a 60-year-old woman died with blood clots in several parts...
Virus Outbreak,Denmark
130
2021-01-25
Thursday, 25 March 2021 08:01 AM
Newsmax Media, Inc.

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

(Optional for Local News)
Privacy: We never share your email address.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
 
TOP

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved
NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved